With the introduction of sensors, wearables and apps we can fullly engage patients in real time to increase the quality of data

On-Demand Webinar Archive

To access the archived recording of this webinar, visit our webinar channel and complete a one time only form. This will give you access to our entire library of archived webinars.

Access Webinar Archive

Key insights

Although not entirely new, use of these technologies is gaining momentum and senior decision makers need to be aware of the potential of this growth area and also the issues and challenges. We typically bring the patient to the clinical trial, but mobile health signals the opportunity of bringing the trial to the patient.

This webinar will focus on free-living activity in clinical trials:

  • The background to use of wearables/sensors
  • Accelerometers and how do they work
  • Examples of the use of sensors today and most common therapeutic areas
  • Barriers to more extensive use covering methodology, technology and regulations
  • Standardization for implementing activity monitors, data management and developing clinical endpoints

Marie McCarthy, MSc, MBA

Marie has been involved in Actigraphy in Clinical Research since May 2009 and has built an impressive academic network in Europe and the US. She has presented at conferences and taught medical staff in the use and utilization of actigraphy devices. She recently published "Can Actigraphy Outcome Measures from existing clinical Trials provide a framework for sleep and activity endpoints standards in the clinical trials of the Future.” McCarthy M,  Muehlhausen W, (2015) ISPOR, (p. Poster PRM239). Milan.

Bill Byrom, PhD

Bill serves as a Senior Director within Product Innovation at ICON, focusing on harnessing new technologies for clinical trials. He has worked in the Pharma industry for over 25 years and is the author of 60+ publications and an industry textbook on electronic Patient Reported Outcomes. Bill contributes to the C-PATH ePRO Consortium and the eClinical Forum. He holds a PhD in disease simulation. Bill can be reached at b[email protected] and via LinkedIn and Twitter (@billbyrom).


Target Audience

This program is intended for leaders in clinical development programs, clinical research scientist with the aim of providing insight into the development of standards in this innovative area.